Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma

Volume: 107, Issue: 6, Pages: 542 - 549
Published: Nov 5, 2020
Abstract
Cabozantinib strongly inhibits osteoclast differentiation and bone resorption in vitro. We aimed to evaluate its effect on bone turnover markers (BTMs) in metastatic renal cell carcinoma.This is a monocentric prospective study on patients with mRCC treated with cabozantinib between October 2016 and July 2018. We collected blood samples at baseline and after 3 and 6 months of treatment. We compared sets of data obtained from plasma samples in the...
Paper Details
Title
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma
Published Date
Nov 5, 2020
Volume
107
Issue
6
Pages
542 - 549
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.